Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥149.8bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥198.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥153.6bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥4.1bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥19.1bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥7.5bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥23.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥21.0bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥4.2bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥21.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥2.8bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥15.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥2.9bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥15.3bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥351.3bnat 2023-12-31Cons.Assets
Total assets¥322.9bnat 2023-03-31Cons.Assets
Total assets¥331.4bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥91.4bnat 2023-12-31Cons.Liabilities
Total liabilities¥67.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥259.9bnat 2023-12-31Cons.Net assets
Net assets / equity¥255.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥255.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥49.6bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥48.1bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥17.062023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-19.682023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥89.362022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.622022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.572022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥17.042023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥89.332022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥90.62022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio73.7%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.9%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥130m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥130m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥5.9bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue2023-04-01 → 2023-12-31¥40.9bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue external2023-04-01 → 2023-12-31¥40.7bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥129m
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentsegment profit2023-04-01 → 2023-12-31¥3.3bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue2023-04-01 → 2023-12-31¥48.3bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue external2023-04-01 → 2023-12-31¥48.3bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥0
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentsegment profit2023-04-01 → 2023-12-31¥888m
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue2023-04-01 → 2023-12-31¥60.7bn
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue external2023-04-01 → 2023-12-31¥60.7bn
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentsegment profit2023-04-01 → 2023-12-31¥5.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥149.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥149.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥130m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥10.0bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥122m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥122m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥5.6bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue2022-04-01 → 2022-12-31¥51.8bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue external2022-04-01 → 2022-12-31¥51.6bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥122m
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentsegment profit2022-04-01 → 2022-12-31¥9.5bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue2022-04-01 → 2022-12-31¥47.2bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue external2022-04-01 → 2022-12-31¥47.2bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥0
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.5bn
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue2022-04-01 → 2022-12-31¥54.8bn
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue external2022-04-01 → 2022-12-31¥54.8bn
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentsegment profit2022-04-01 → 2022-12-31¥6.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥153.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥153.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥122m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥24.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 387
ItemContextValueUnit
Investment securitiesCurrentQuarterInstant41935000000JPY
Net defined benefit assetPrior1YearInstant3845000000JPY
Net defined benefit assetCurrentQuarterInstant3971000000JPY
Other ioaPrior1YearInstant5084000000JPY
Other ioaCurrentQuarterInstant5402000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-54000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-54000000JPY
Investments and other assetsPrior1YearInstant41021000000JPY
Investments and other assetsCurrentQuarterInstant51254000000JPY
Noncurrent assetsPrior1YearInstant136820000000JPY
Noncurrent assetsCurrentQuarterInstant150449000000JPY
AssetsPrior1YearInstant322858000000JPY
AssetsCurrentQuarterInstant351294000000JPY
Notes and accounts payable tradePrior1YearInstant16239000000JPY
Notes and accounts payable tradeCurrentQuarterInstant21329000000JPY
Short term loans payablePrior1YearInstant3380000000JPY
Short term loans payableCurrentQuarterInstant12666000000JPY
Current portion of bondsPrior1YearInstant-JPY
Current portion of bondsCurrentQuarterInstant8000000000JPY
Accounts payable otherPrior1YearInstant10662000000JPY
Accounts payable otherCurrentQuarterInstant14566000000JPY
Income taxes payablePrior1YearInstant2133000000JPY
Income taxes payableCurrentQuarterInstant1102000000JPY
Other clPrior1YearInstant6633000000JPY
Other clCurrentQuarterInstant6830000000JPY
Current liabilitiesPrior1YearInstant39049000000JPY
Current liabilitiesCurrentQuarterInstant64495000000JPY
Bonds payablePrior1YearInstant8000000000JPY
Bonds payableCurrentQuarterInstant-JPY
Long term loans payablePrior1YearInstant8200000000JPY
Long term loans payableCurrentQuarterInstant13500000000JPY
Net defined benefit liabilityPrior1YearInstant395000000JPY
Net defined benefit liabilityCurrentQuarterInstant408000000JPY
Other nclPrior1YearInstant12186000000JPY
Other nclCurrentQuarterInstant12979000000JPY
Noncurrent liabilitiesPrior1YearInstant28782000000JPY
Noncurrent liabilitiesCurrentQuarterInstant26887000000JPY
LiabilitiesPrior1YearInstant67831000000JPY
LiabilitiesCurrentQuarterInstant91383000000JPY
Capital stockPrior1YearInstant14932000000JPY
Capital stockCurrentQuarterInstant14932000000JPY
Capital surplusPrior1YearInstant15803000000JPY
Capital surplusCurrentQuarterInstant15828000000JPY
Retained earningsPrior1YearInstant202976000000JPY
Retained earningsCurrentQuarterInstant197929000000JPY
Treasury stockPrior1YearInstant-5523000000JPY
Treasury stockCurrentQuarterInstant-5412000000JPY
Shareholders equityPrior1YearInstant228189000000JPY
Shareholders equityCurrentQuarterInstant223278000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant8023000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass